This document lists the medicines eligible for supply through the Northern Ireland MHRA Authorised Route (NIMAR).
The listed medicines may be dispatched from Great Britain to Northern Ireland on the basis of the medicines authorisation in Great Britain.
This list is maintained and published in accordance with regulation 167B (list of NIMAR products) of the Human Medicines Regulations 2012 (SI 2012/1916, as amended).
Updates to this page
Published 16 December 2021 Last updated 27 December 2024 +show all updates
Updated to add products to the list. Added: Tresiba Penfill 100units/ml solution for injection 3ml cartridges - Insulin degludec 100units/ml solution for injection 3ml cartridges; Tresiba FlexTouch 200units/ml solution for injection 3ml pre-filled pens - Insulin degludec 200units/ml solution for injection 3ml pre-filled disposable devices; Levemir Penfill 100units/ml solution for injection 3ml cartridges - Insulin detemir 100units/ml solution for injection 3ml cartridges; Levemir FlexPen 100units/ml solution for injection 3ml pre-filled pens - Insulin detemir 100units/ml solution for injection 3ml pre-filled disposable devices; NovoRapid 100units/ml solution for injection 10ml vials - Insulin aspart 100units/ml solution for injection 10ml vials; NovoRapid Penfill 100units/ml solution for injection 3ml cartridges - Insulin aspart 100units/ml solution for injection 3ml cartridges; Fiasp 100units/ml solution for injection 10ml vials - Insulin aspart 100units/ml solution for injection 10ml vials; NovoMix 30 FlexPen 100units/ml suspension for injection 3ml pre-filled pens - Insulin aspart biphasic 30/70 100units/ml suspension for injection 3ml pre-filled disposable devices; Xeljanz 1mg/ml oral solution - Tofacitinib 1mg/ml oral solution sugar free; Talzenna 0.1mg capsules - Talazoparib 100microgram capsules; Talzenna 1mg capsules - Talazoparib 1mg capsules; Zinforo 600mg powder for concentrate for solution for infusion vials - Ceftaroline fosamil 600mg powder for solution for infusion vials; and Rapamune 1mg/ml oral solution - Sirolimus 1mg/ml oral solution sugar free.
Updated to add: Lutathera 7,400MBq/20.5-25ml solution for infusion vials - Lutetium (Lu-177) oxodotreotide 7,400MBq/20.5-25ml solution for infusion vials.
Updated to add and remove products from the list. Added: Aprepitant 125mg capsules and Aprepitant 80mg capsules. Removed: Briviact 10mg/ml oral solution - Brivaracetam 50mg/5ml oral solution sugar free.
Updated to add products to the list. Added: Emblaveo 1.5g/0.5g powder for concentrate for solution for infusion vials - Aztreonam 1.5g / Avibactam 500mg powder for solution for infusion vials.
Updated to add items to the list and to correct one item. Added: Zubsolv 1.4mg/0.36mg sublingual tablets - Buprenorphine 1.4mg / Naloxone 360microgram sublingual tablets sugar free; Zubsolv 2.9mg/0.71mg sublingual tablets - Buprenorphine 2.9mg / Naloxone 710microgram sublingual tablets sugar free; Zubsolv 5.7mg/1.4mg sublingual tablets - Buprenorphine 5.7mg / Naloxone 1.4mg sublingual tablets sugar free; and Zubsolv 8.6mg/2.1mg sublingual tablets - Buprenorphine 8.6mg / Naloxone 2.1mg sublingual tablets sugar free. Corrected: 'Methotrexate 15mg/0.3ml solution for injection pre-filled syringes' to 'Methotrexate 15mg/0.3ml solution for injection pre-filled pens'.
Updated to add and remove products from the list: Added: Vegzelma 100mg/4ml concentrate for solution for infusion vials - Bevacizumab 100mg/4ml solution for infusion vials; and Vegzelma 400mg/16ml concentrate for solution for infusion vial - Bevacizumab 400mg/16ml solution for infusion vials. Removed: Levemir Innolet 100 units/ml solution for injection 3 ml pre filled pens - Insulin Detemir 100 units/ml solution for injection 3ml pre filled disposable devices; and Insulatard Innolet 100 units/ml suspension for injection 3ml pre filled pen - Insulin Isophane human 100 units/ml suspension for injection 3 ml pre filled disposable devices.
Updated to add the following products: Quetiapine 50mg modified-release tablets; Quetiapine 150mg modified-release tablets; Quetiapine 200mg modified-release tablets; Quetiapine 300mg modified-release tablets; Quetiapine 400mg modified-release tablets; and Vinorelbine 10mg/1ml concentrate for solution for infusion vials.
Updated to add and remove products from the list. Added: Methotrexate 15mg/0.3ml solution for injection pre-filled syringes; Neratinib 40mg tablets; Vimpat 150mg tablets - Lacosamide 150mg tablets; Voriconazole 200mg/5ml oral suspension; Lorlatinib 100mg tablets; Vyloy 100mg powder for concentrate for solution for infusion vials - Zolbetuximab 100mg powder for solution for infusion vials; and Entresto 15mg/16mg granules in capsules for opening - Sacubitril 15mg/Valsartan 16mg granules in capsules for opening. Removed: Zonegran 50mg capsules - Zonisamide 50mg capsules.
Updated to add: Methylthioninium chloride (methylene blue) 50mg/10ml solution for injection ampoules.
Updated to add: Ayvakyt 200mg tablets - Avapritinib 200mg tablets.
